human monoclonal antibodies (Astellas Pharma)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehuman monoclonal antibodies (Astellas Pharma)
Drug Alias Namehuman monoclonal antibodies (Evec)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCytomegalovirus InfectionsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvec Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvec IncAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsCytomegalovirus InfectionsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A